Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eosinophilic COPD”

26 trials

Showing 20 of 26 results

Large-scale testing (Phase 3)Looking for participantsNCT07177339
What this trial is testing

EValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 1,196
Not applicableStudy completedNCT01634620
What this trial is testing

Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Aerocrine AB 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07780656
What this trial is testing

Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 624
Post-approval studies (Phase 4)UnknownNCT02546349
What this trial is testing

Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMA

Who this might be right for
COPD
Taipei Veterans General Hospital, Taiwan 143
Testing effectiveness (Phase 2)Active Not RecruitingNCT06533553
What this trial is testing

Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Areteia Therapeutics 30
Large-scale testing (Phase 3)Looking for participantsNCT06959095
What this trial is testing

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 981
Not applicableStudy completedNCT07788092
What this trial is testing

Dupilumab in Type 2-Inflamed COPD Across the Full Spectrum of Airflow Limitation: An Italian Multicentre Retrospective Cohort Study

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)COPDEosinophilia
Azienda Ospedaliera di Perugia 40
Not applicableStudy completedNCT03436511
What this trial is testing

Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 341
Not applicableLooking for participantsNCT06862206
What this trial is testing

This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 1,000
Large-scale testing (Phase 3)Looking for participantsNCT07190222
What this trial is testing

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sanofi 942
Large-scale testing (Phase 3)Looking for participantsNCT07780669
What this trial is testing

Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 624
Not applicableUnknownNCT05398133
What this trial is testing

Phenotype Assessment of Blood and Airway Eosinophils in Patients With COPD and Asthma

Who this might be right for
COPD AsthmaEosinophilic Asthma
Medical University of Warsaw 36
Large-scale testing (Phase 3)Study completedNCT01463644
What this trial is testing

Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis

Who this might be right for
Chronic Obstructive Pulmonary DiseasesChronic Airways LimitationBronchitis
McMaster University 18
Not applicableUnknownNCT04008017
What this trial is testing

Eosinophilic Cationic Protein as a Biomarker in Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Assiut University 64
Large-scale testing (Phase 3)Study completedNCT04075331
What this trial is testing

Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial

Who this might be right for
COPDEosinophilia
University of Leicester 238
Large-scale testing (Phase 3)Looking for participantsNCT06961214
What this trial is testing

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 960
Not applicableUnknownNCT04961060
What this trial is testing

Drivers of Eosinophilic COPD Exacerbations

Who this might be right for
COPD ExacerbationEosinophilia
University Medical Center Groningen 100
Post-approval studies (Phase 4)Study completedNCT00292838
What this trial is testing

Relative Potency of Inhaled Corticosteroids

Who this might be right for
AsthmaChronic Obstructive Pulmonary Disease (COPD)
St. Joseph's Healthcare Hamilton 40
Large-scale testing (Phase 3)Looking for participantsNCT07190209
What this trial is testing

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sanofi 942
Post-approval studies (Phase 4)Not Yet RecruitingNCT07587658
What this trial is testing

This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Regeneron Pharmaceuticals 754
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation